Avoiding routine #defibrillation testing during subcutaneous implantable #cardioverter defibrillator placement maintains device efficacy while significantly reducing the risk for short-term complications.

https://www.thecardiologyadvisor.com/news/omitting-defibrillation-testing-sicd-implantation/